Related references
Note: Only part of the references are listed.Diagnosis and Treatment of Helicobacter pylori Infection
Yi-Chia Lee et al.
ANNUAL REVIEW OF MEDICINE (2022)
Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED)
Marco Romano et al.
DIGESTIVE AND LIVER DISEASE (2022)
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
Peter Malfertheiner et al.
GUT (2022)
Comparative Effectiveness of Various Eradication Regimens for Helicobacter Pylori Infection in the Northeastern Region of Poland
Justyna Wasielica-Berger et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)
Is a Potassium-Competitive Acid Blocker Truly Superior to Proton Pump Inhibitors in Terms of Helicobacter pylori Eradication?
Soichiro Sue et al.
GUT AND LIVER (2021)
Single Capsule Bismuth Quadruple Therapy for Eradication of H. pylori Infection: A Real-Life Study
Antonietta G. Gravina et al.
FRONTIERS IN PHARMACOLOGY (2021)
Efficacy and safety of twice a day, bismuth-containing quadruple therapy using high-dose tetracycline and metronidazole for second-line Helicobacter pylori eradication
Ji Yeon Kim et al.
HELICOBACTER (2020)
Efficacy of Vonoprazan for Helicobacter pylori Eradication
Shu Kiyotoki et al.
INTERNAL MEDICINE (2020)
Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study
Marco Romano et al.
HELICOBACTER (2020)
Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg)
Olga P. Nyssen et al.
HELICOBACTER (2020)
A randomized, multicenter and noninferiority study of amoxicillin plus berberine vs tetracycline plus furazolidone in quadruple therapy for Helicobacter pylori rescue treatment
Jian Zhang et al.
JOURNAL OF DIGESTIVE DISEASES (2020)
Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy forHelicobacter pyloriinfection: Spanish data of the EuropeanHelicobacter pyloriRegistry (Hp-EuReg)
Olga P. Nyssen et al.
HELICOBACTER (2020)
Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus
Jyh-Ming Liou et al.
GUT (2020)
Meta-analysis of three-in-one single capsule bismuth-containing quadruple therapy for the eradication of Helicobacter pylori
Olga P. Nyssen et al.
HELICOBACTER (2019)
Randomised controlled trial: susceptibility-guided therapy versus empiric bismuth quadruple therapy for first-line Helicobacter pylori treatment
Qi Chen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Compliance, adverse effects and effectiveness of first line bismuth-containing quadruple treatment (Pylera®) to eradicate Helicobacter pylori infection in 200 patients
Manuel Castro-Fernandez et al.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (2019)
Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
Yong Xie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States
Hashem B. El-Serag et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Effectiveness and Safety of Pylera® in Patients Infected by Helicobacter Pylori: A Multicenter, Retrospective, Real Life Study
Antonio Tursi et al.
DIGESTIVE DISEASES (2018)
Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection
Wen Zhong Liu et al.
HELICOBACTER (2018)
The three-in-one formulation of bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotics supplementation: Efficacy and safety in daily clinical practice
Rocco Maurizio Zagari et al.
HELICOBACTER (2018)
Eradication Rates in Italian Subjects Heterogeneously Managed for Helicobacter pylori Infection. Time to Abandon Empiric Treatments in Southern Europe
Agostino Di Ciaula et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2017)
Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication
Y. S. Jung et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial
Liya Zhou et al.
HELICOBACTER (2016)
Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial
Ju Yup Lee et al.
BMC GASTROENTEROLOGY (2016)
Pathobiology of Helicobacter pylori-Induced Gastric Cancer
Manuel Amieva et al.
GASTROENTEROLOGY (2016)
Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects
H. Jenkins et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Kyoto global consensus report on Helicobacter pylori gastritis
Kentaro Sugano et al.
GUT (2015)
Meta-analysis: Is combination of tetracycline and amoxicillin suitable for Helicobacter pylori infection?
Zhi-Fa Lv et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Helicobacter Pylori First-Line and Rescue Treatments in the Presence of Penicillin Allergy
Javier P. Gisbert et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Ten-Day Quadruple Therapy Comprising Proton-Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin Achieves a High Eradication Rate for Helicobacter pylori Infection after Failure of Sequential Therapy
Ping-I Hsu et al.
HELICOBACTER (2014)
Tetracycline- and Furazolidone-containing Quadruple Regimen as Rescue Treatment for Helicobacter pylori Infection: A Single Center Retrospective Study
Yuemiao Zhang et al.
HELICOBACTER (2014)
Efficacy of Bismuth-Containing Quadruple Therapies for Clarithromycin-, Metronidazole-, and Fluoroquinolone-Resistant Helicobacter pylori Infections in a Prospective Study
Xiao Liang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Antibiotic Resistance of Helicobacter Pylori Isolated in the Southeast Coastal Region of China
Peng Su et al.
HELICOBACTER (2013)
Letter to the Editor: Translational research is a necessity for selecting the best components of the extracorporeal circuitry for neonatal and pediatric CPB patients
A. Undar et al.
PERFUSION-UK (2013)
Comparison of the efficacy of triple versus quadruple therapy on the eradication of Helicobacter pylori and antibiotic resistance
Qing Zheng et al.
JOURNAL OF DIGESTIVE DISEASES (2010)
Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication
Jaime N. Eisig et al.
BMC GASTROENTEROLOGY (2009)
Furazolidone, amoxicillin, bismuth and rabeprazole quadruple rescue therapy for the eradication of Helicobacter pylori
Hong Cheng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Tetracycline, metronidazole and amoxicillin-metronidazole combinations in proton pump inhibitor-based triple therapies are equally effective as alternative therapies against Helicobacter pylori infection
M Matsushima et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Helicobacter pylori first-line treatment and rescue options in patients allergic to penicillin
JP Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
High eradication rates of Helicobacter pylori infection with first- and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillin
M Rodríguez-Torres et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
Helicobacter pylori 'rescue' regimen when proton pump inhibitor-based triple therapies fail
JP Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance
I Chopra et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2001)
Share Paper
